A Study of RGT001-075 in Adult Patients With Obesity
This study is being conducted to evaluate RGT001-075 to help people who are above a healthy weight range to lose weight. In this study participants will either get RGT001-075 or a "dummy" medicine (placebo). Which treatment participants get is decided by chance. Participants need to take RGT001-075 or placebo once every day for 12 weeks.
- EligibilityCriteria: Inclusion Criteria:  Age ≥ 18 and ≤ 75 years Have a BMI ≥27 kg/m² and ≤ 45 kg/m² Have had a stable body weight for the 3 months prior to randomization  Exclusion Criteria:  Have obesity induced by other endocrinologic disorders or diagnosed monogenetic or syndromic forms of obesity Have a prior or planned surgical treatment for obesity Have or plan to have endoscopic and/or device-based therapy for obesity Have any prior diagnosis of diabetes Have an electrocardiogram (ECG) with abnormalities Have a history of Major Depressive Disorder (MDD) or other severe psychiatric disorders within the last 2 years Have a history of suicide attempt. - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - MaximumAge: 75 Years - StdAgeList: Adult, Older Adult